$142.21
5.04% today
Nasdaq, Feb 28, 05:18 pm CET
ISIN
US44930G1076
Symbol
ICUI

ICU Medical, Inc. Stock price

$149.75
-22.53 13.08% 1M
-14.16 8.64% 6M
-5.42 3.49% YTD
+42.94 40.20% 1Y
-86.98 36.74% 3Y
-50.60 25.26% 5Y
+60.84 68.43% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-4.52 2.93%
ISIN
US44930G1076
Symbol
ICUI
Sector

Key metrics

Market capitalization $3.67b
Enterprise Value $5.01b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 29.52
EV/Sales (TTM) EV/Sales 2.14
P/S ratio (TTM) P/S ratio 1.57
P/B ratio (TTM) P/B ratio 1.79
Revenue growth (TTM) Revenue growth 3.99%
Revenue (TTM) Revenue $2.34b
EBIT (operating result TTM) EBIT $28.56m
Free Cash Flow (TTM) Free Cash Flow $169.88m
Cash position $312.51m
EPS (TTM) EPS $-4.57
P/E forward negative
P/S forward 1.63
EV/Sales forward 2.21
Short interest 4.74%
Show more

Is ICU Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

ICU Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a ICU Medical, Inc. forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a ICU Medical, Inc. forecast:

Buy
67%
Hold
33%

Financial data from ICU Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,338 2,338
4% 4%
100%
- Direct Costs 1,586 1,586
3% 3%
68%
752 752
5% 5%
32%
- Selling and Administrative Expenses 405 405
248% 248%
17%
- Research and Development Expense 89 89
3% 3%
4%
258 258
50% 50%
11%
- Depreciation and Amortization 229 229
50% 50%
10%
EBIT (Operating Income) EBIT 29 29
44% 44%
1%
Net Profit -111 -111
296% 296%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about ICU Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICU Medical, Inc. Stock News

Neutral
Seeking Alpha
about 13 hours ago
ICU Medical, Inc. (NASDAQ:ICUI ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Brett Fishbin - KeyBanc Capital Markets Charlie Strauzer - CJS Securities Michael Toomey - Jefferies Joseph Conway - Needham Opera...
Neutral
GlobeNewsWire
about 20 hours ago
SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2024.
Neutral
GlobeNewsWire
15 days ago
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 46th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-5, 2025. ICU Medical's presentation will be on Monday, March 3, 2025 at...
More ICU Medical, Inc. News

Company Profile

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Head office United States
CEO Vivek Jain
Employees 14,000
Founded 1984
Website www.icumed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today